Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions?
Dimitrios Giannis, James D. Douketis, Alex C. Spyropoulos
European Journal of Internal Medicine (2021) Vol. 96, pp. 13-16
Open Access | Times Cited: 9

Showing 9 citing articles:

Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review
Stefano Ballestri, Elisa Romagnoli, Dimitriy Arioli, et al.
Advances in Therapy (2022) Vol. 40, Iss. 1, pp. 41-66
Open Access | Times Cited: 53
Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials
Eros Pilia, Alessandro Belletti, Stefano Fresilli, et al.
Journal of Thrombosis and Thrombolysis (2022) Vol. 54, Iss. 3, pp. 420-430
Open Access | Times Cited: 20
The Role of Heparin in COVID-19: An Update after Two Years of Pandemics
Marco Mangiafico, Andrea Caff, Luca Costanzo
Journal of Clinical Medicine (2022) Vol. 11, Iss. 11, pp. 3099-3099
Open Access | Times Cited: 15
Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19
Rosaria Sofia, Mattias Carbone, Giovanni Landoni, et al.
European Journal of Internal Medicine (2022) Vol. 100, pp. 21-24
Open Access | Times Cited: 11
Efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with COVID-19 pneumonia
José F. Varona, Elena Núñez, Borja Manuel Fernández Félix, et al.
European Journal of Internal Medicine (2022) Vol. 99, pp. 106-108
Open Access | Times Cited: 4
Type 1, Type 2 Myocardial Infarction and Non-Ischemic Myocardial Injury—Opinion from the Front Lines
Joseph S. Alpert, Allan S. Jaffe, Harvey D. White, et al.
The American Journal of Medicine (2022) Vol. 135, Iss. 8, pp. 935-938
Closed Access | Times Cited: 4
Effect of Heparin and Tocilizumab in Patients with Severe COVID-19: The HEPMAB Randomized Clinical Trial
Lucas Trindade Cantú Ribeiro, Lucas Trindade Cantú Ribeiro, Giovanni Landoni, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Coronavirus Disease 2019-Related Extensive Thrombosis in a Patient Receiving Therapeutic Anticoagulation With Dabigatran
Robert C. Ross, Andrew L. Hendrickson, Miranda Boraas, et al.
Hospital Pharmacy (2022) Vol. 57, Iss. 6, pp. 774-778
Closed Access | Times Cited: 1
The role of heparin in reducing in-hospital complications and three-month mortality rates in hospitalized COVID-19 patients
Francesca Calabretta, Paola Preti, Maria Francesca Russo, et al.
European Journal of Internal Medicine (2022) Vol. 101, pp. 124-127
Open Access
Page 1

Scroll to top